Cargando…
Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine
Poly(d,l-lactic-co-glycolic) (PLGA) nanoparticles (NPs) have been widely studied for several applications due to their advantageous properties, such as biocompatibility and biodegradability. Therefore, these nanocarriers could be a suitable approach for glioblastoma multiforme (GBM) therapy. The tre...
Autores principales: | Ramalho, Maria João, Loureiro, Joana A., Coelho, Manuel A. N., Pereira, Maria Carmo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722980/ https://www.ncbi.nlm.nih.gov/pubmed/31405159 http://dx.doi.org/10.3390/pharmaceutics11080401 |
Ejemplares similares
-
Transferrin-Conjugated
PLGA Nanoparticles for Co-Delivery
of Temozolomide and Bortezomib to Glioblastoma Cells
por: Ramalho, Maria João, et al.
Publicado: (2023) -
PLGA nanoparticles as a platform for vitamin D-based cancer therapy
por: Ramalho, Maria J, et al.
Publicado: (2015) -
Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.
por: Wedge, S. R., et al.
Publicado: (1996) -
Redox-Responsive Magnetic Nanoparticle for Targeted Convection-Enhanced Delivery of O(6)-Benzylguanine to Brain Tumors
por: Stephen, Zachary R., et al.
Publicado: (2014) -
PLGA Based Drug Carrier and Pharmaceutical Applications: The Most Recent Advances
por: Loureiro, Joana Angélica, et al.
Publicado: (2020)